GLPwatch
Trials (2036)
Page 24 of 34.
- Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
- Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)
- Liraglutide as add-on to Insulin in Type 1 Diabetes
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical Practice
- Treatment of GLP-1 for Diabetic Bariatric Patients
- A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus
- Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
- A Study of LY3841136 in Overweight and Obese Participants
- A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects
- Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project)
- Spartina® (Tirzepatide) Effectiveness and Safety Evaluation
- A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
- Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
- Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
- Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients
- Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?
- Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D
- The Effect of a Liraglutide on IVF in Obese PCOS
- A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
- This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control
- LY2189265 and Atorvastatin Interaction Study
- A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
- A Study of LY3502970 in Participants With Impaired and Normal Liver Function
- Liraglutide for HIV-associated Neurocognitive Disorder
- Tirzepatide and Muscle Outcomes in Obesity
- A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in Italy
- A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
- Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
- Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
- Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes
- Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
- Liraglutide 3 mg for Knee Osteoarthritis
- A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
- A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body
- Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity
- Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
- A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjects
- An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
- Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults
- A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients
- Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide
- Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
- A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
- The Lira Pump Trial
- Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention
- A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)
- Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes
- Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes
- The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
- A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
- The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
- A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
- A Study of TG103 Injection in Type 2 Diabetes Subjects
- A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus
- Liraglutide Effects on Memory in Healthy Subjects
- Exenatide and Brown Adipose Tissue
- A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
- An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus